# Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

> **NCT00388531** · PHASE2 · COMPLETED · sponsor: **PETHEMA Foundation** · enrollment: 10 (estimated)

## Conditions studied

- Lymphoblastic Leukemia
- Lymphoma

## Interventions

- **DRUG:** Depocyte®

## Key facts

- **NCT ID:** NCT00388531
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00388531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00388531, "Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00388531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*